Cognitive Assessment Tools for Huntington's Disease.

Part of paid clinical trials in Columbus, Ohio.

Sponsor
Ohio State University
Study ID
NCT06546488
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
30 Years - 65 Years
Healthy Volunteers
Not accepted

Interventions

  • Assessments — BEHAVIORAL
    A standardized assessment battery will be administered. It will consist of cognitive, functional and motor assessments.

Study Details

The purpose of the current proposal is to expand understanding of two currently available cognitive tools that are not typically used in Huntington Disease (HD) clinical trials that might be useful both for initial screening and for clinical trial application. One is the Coding Test and the other is the Self-Administered Gerocognitive Examination (SAGE). Both the Coding Test and the SAGE have been used for assessments of individuals with other neurodegenerative diseases, including Alzheimer's Disease, Parkinson's Disease and Lewy Body Disease, but data is lacking on their use in individuals with HD.

Key Dates

Start date
Jun 20, 2025
Status verified
Feb 2026
Primary completion
Dec 1, 2027
Completion
Dec 1, 2027

Study Design

Enrollment
76 participants (estimated)

Arms

  • Arm: Subject population
    All subjects who meet the inclusion/exclusion criteria for the trial.

Primary Outcome Measure

Symbol Digit Modality Test (SDMT) compared to the Coding Test [ Time Frame: One day visit ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
The Ohio State University Wexner Medical CenterColumbusOhio43221
Nicole Vrettos
Sandra Kostyk, MD, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Columbus, OH

By condition
Huntington disease
By specialty
NeurologyBrain disorders
By research site
The Ohio State University Wexner Medical Center· Columbus, OH

Related Studies